Buy Klimonorm (Estradiol, Levonorgestrel) 21 dragee

Homepage

Hormonal Disorders

Klimonorm (Estradiol, Levonorgestrel) 21 dragee

Description

Features

Reviews

Instructions for Klimonorm (Estradiol, Levonorgestrel) 21 dragee

English Product Name
Klimonorm®

Release Form
Drazhe

Description Klimonorm:

Two species.

Round drage, yellow color (9 pcs. in blister).

1 drage
estradiola valerat 2 mg
Auxiliaries:
lactose monohydrate,
potato starch,
gelatin,
magnesium stearate,
saccharose,
dextrose (glucose), macrogol 35 000,
polyvidon K25 talc,
magnesium carbonate basic,
calcium carbonate, titanium dioxide,
iron oxide hydrate,
carnaubian wax,
purified water.

Drage round, brown (12 pcs in blister).

1 drage
estradiola valerat 2 mg
levonorgestrel 150 ug
Auxiliaries: lactose monohydrate, potato starch, gelatin, magnesium stearate, saccharose, dextrose (glucose), macrogol 35 000, polyvidon K25 talc, magnesium carbonate basic, calcium carbonate, titanium dioxide, iron oxide red, iron oxide brown, carnaub wax, purified water.

21 pcs. - blisters (1) - cardboard packs.
21 pcs. - blisters (3) - cardboard packs.

ATX codes
G03FB09 Levonorgestrel and estrogen

Clinical and pharmacological groups / Group affiliation
Anti-climacteric drug

Active substance
estradiola valerat
levonorgestrel

Pharmacotherapeutic group:

Anti-climacteric agent (estrogen + progestagen)

Indications Klimonorm:

Alternate hormone therapy (SGT) for climacteric disorders,
invasive changes in the skin and urinary tract,
depressive conditions in the climacteric period,
and symptoms of estrogen deficiency due to natural menopause or gi ovarian hypogonadism,
sterilization,
or primary dysfunction in women with the uterus not removed;
prevention of postmenopausal osteoporosis;
normalization of irregular menstrual cycles;
Treatment of primary or secondary amenorrhea.

Method of application, course and dosage Klimonorm:

Inside. The dosing mode is individual depending on the patient's indications, age and clinical situation.

Pharmacological effect Klimonorm:

Anti-climacteric drug containing estrogen and gestagen
Estradiola valerate (estrogen) in the human body turns into a natural 17 β-estradiol.
The addition of Levonorgestrel gestagen within 12 days of each cycle prevents the development of hyperplasia and endometrial cancer.

Due to the composition and cyclic pattern of intake (intake of estrogen only for 9 days, followed by a combination of estrogen and gestagen for 12 days and then a 7-day break), menstrual cycle is established in women with a non-removed uterus at regular intake.

Estradiol recovers estrogen deficiency in the female body after menopause and provides effective treatment for psycho-emotional and vegetative climacteric symptoms (such as high tides, increased sweating, sleep disturbance, increased nervous excitability, irritation) Frustration, heartbeats, cardialgias, dizziness, headache, reduced libido, muscle and joint pain); Involution of the skin and mucous membranes, especially the mucous urogenital system (urinary incontinence, dryness and irritation of the mucous vagina, pain in sexual intercourse).

Application for liver function disorders
The use in liver tumors at present or in anamnesis (benign or malignant), severe liver diseases is inversely demonstrated.

Caution when cholestatic jaundice or cholestatic itching during pregnancy.

In case of severe liver function disorders, including various forms of hyperbilirubinemia, such as Dubin-Johnson syndrome or Rotor syndrome, medical observation is required, as well as periodic studies of liver function. In case of deterioration of liver function parameters, GTC should be canceled.